A golden year of innovative kidney disease therapeutics
Nat Rev Nephrol
.
2025 Jan 3.
doi: 10.1038/s41581-024-00916-z.
Online ahead of print.
Authors
Monica Suet Ying Ng
1
2
3
4
,
Carmel M Hawley
5
6
7
Affiliations
1
Kidney Health Service, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
2
Conjoint Internal Medicine Laboratory, Pathology Queensland, Herston, Queensland, Australia.
3
Faculty of Medicine, University of Queensland, Herston, Queensland, Australia.
4
Institute of Molecular Biosciences, University of Queensland, Saint Lucia, Queensland, Australia.
5
Department of Kidney and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
[email protected]
.
6
Translational Research Institute, Woolloongabba, Queensland, Australia.
[email protected]
.
7
Centre for Kidney Disease Research, University of Queensland, Woolloongabba, Queensland, Australia.
[email protected]
.
PMID:
39753690
DOI:
10.1038/s41581-024-00916-z
No abstract available